Stroke Diagnostics & Therapeutics - $49.7 Billion Worldwide Market Outlook to 2026 featuring Siemens, GE, Medtronic, Bayer, Abbott, Merck, BMS, and More - ResearchAndMarkets.com
Aug. 29, 2018
DUBLIN--(BUSINESS WIRE)--Aug 29, 2018--The "Stroke Diagnostics and Therapeutics - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
According to the report, the market accounted for $23,849.39 Million in 2017 and is expected to reach $49,698.68 Million by 2026 growing at a CAGR of 8.5% during the forecast period.
Factors such as technological advancement, growing aging population, and people suffering from diabetes are favoring the market. On the other hand, increasing health expenditure, hypertension and also increasing tobacco users are also fuelling the market. However factors such as unfavorable reimbursement scenario and high cost of treatments are hampering the market growth.
By Geography, Asia is expected to witness high growth rate and is expected to remain on top among other regions in the forecast period due to growing aging population, evolving R&D activities for drug discovery and development, increasing government support in the form of funding and developing healthcare infrastructure in the region. In addition, growing demographics and economies in the developing countries such as India, China, and Japan are expected to lead the growth in the stroke diagnostics and therapeutics market in Asia.
Key Topics Covered
1 Executive Summary
3 Market Trend Analysis
4 Porter's Five Force Analysis
5 Global Stroke Diagnostics and Therapeutics Market, By Type
6 Global Stroke Diagnostics and Therapeutics Market, By Application
7 Global Stroke Diagnostics and Therapeutics Market, By Geography
8 Key Developments
9 Company ProfilingSiemens AG GE Healthcare Medtronic PLC Bayer AG Abbott Laboratories Cordis Corporation Boston Scientific Corporation Genentech Inc. Koninklijke Philips N.V. Stryker Corporation Merck & Co. Inc. B. Braun Melsungen AG Teleflex Inc. Cardinal Health Merck Sharp & Dohme Corp. GlaxoSmithKline PLC Bristol-Myers Squibb Boehringer Ingelheim Johnson & Johnson Daiichi Sankyo
For more information about this report visit https://www.researchandmarkets.com/research/vkmss7/stroke?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180829005273/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Diagnostics,Cardiovascular Drugs,Cardiology
INDUSTRY KEYWORD: HEALTH CARDIOLOGY MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/29/2018 05:42 AM/DISC: 08/29/2018 05:42 AM